Abstract
The pandemic of the metabolic syndrome affects at least 25% of the global population, characterized by a couple of associated pathological effects, such as diabetes, obesity, inflammation, an increase in cholesterol, and hypertension, which can result in cardiopathies, amongst other diseases. Currently, most of the efforts to combat this syndrome are reflected in attempts to control nucle…